TD Cowen's aggressive downgrade and 50% PT cut are a sharp contrarian call against a bullish consensus, but the firm's below-average accuracy tempers the signal. The heavy insider selling and the stock trading near the new PT suggest downside may already be priced in, while the upcoming earnings on Nov 26 could be a catalyst for either convergence or divergence.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $171.97entry
- T+1 · 13d ago −7.08%α −8.73% · $159.80
- T+5 · 7d ago −10.22%α −9.64% · $154.39
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
TD Cowen slashed its price target on Marvell Technology (MRVL) by 50% to $175 from $350 and downgraded the stock from Buy to Hold on November 3, 2026. The stock currently trades at $171.41, slightly below the new target. TD Cowen's accuracy on rated stocks is 45% on 2,051 calls, below the average of firms covering MRVL. The consensus remains heavily bullish with 48 of 53 analysts at Buy or Strong Buy, but the mean price target of $333.09 implies 94% upside from current levels, a wide gap that suggests significant downside risk if the downgrade is correct. In the last 30 days, there have been 1 upgrade and 2 downgrades, and EPS revisions have been predominantly upward (26 up vs 1 down for the +1y period). Insider selling has been heavy, with the CEO, COO, and other executives selling over $7.2 million in open-market transactions in recent weeks, mostly under 10b5-1 plans. Congressional trades show small sells by two members. The next earnings date is November 26, 2026, within 30 days, adding a timing factor. The bottom line: TD Cowen's aggressive PT cut and downgrade stand in stark contrast to the bullish consensus, but the firm's below-average accuracy and the stock's proximity to the new target suggest the market may already be pricing in the bearish view.
Impact Score
Consensus & Targets
The consensus is heavily bullish: 13 Strong Buy, 35 Buy, 5 Hold, 0 Sell, 0 Strong Sell across 53 analysts. 90.6% of analysts rate MRVL at Buy or Strong Buy. TD Cowen's Hold is a contrarian call relative to the overwhelming bullish consensus.
Mean price target is $333.09, median $335, high $450, low $225. Current price $171.41 implies 94.3% upside to the mean. TD Cowen's $175 PT is the lowest among all analysts, well below the $225 low from Cantor Fitzgerald and B of A Securities, and 47.5% below the mean.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-03 | TD Cowen | downgrade | Hold | $175.00 |
| 2026-11-03 | RBC Capital | maintain | Outperform | $250.00 |
| 2026-11-03 | Susquehanna | maintain | Positive | $300.00 |
| 2026-11-03 | Rosenblatt | maintain | Buy | $300.00 |
| 2026-11-03 | Cantor Fitzgerald | maintain | Neutral | $225.00 |
| 2026-11-03 | Needham | maintain | Buy | No target |
| 2026-11-03 | B of A Securities | downgrade | Neutral | $225.00 |
| 2026-10-07 | UBS | maintain | Buy | No target |
| 2026-10-07 | Jefferies | maintain | Buy | No target |
| 2026-10-07 | JP Morgan | maintain | Overweight | No target |
In the last 30 days, there have been 1 upgrade and 2 downgrades. EPS revisions are trending higher: 26 upward revisions vs 1 downward for the +1y period, and 6 up vs 1 down for the current fiscal year. The 30-day EPS estimate for +1y rose from $6.75 to $7.36, a 9.0% increase. This positive revision momentum contrasts with the bearish rating action.
Firm Track Record: TD Cowen
TD Cowen accuracy: 45% on 2051 calls | avg return: 3.6%
Industry benchmark: mean 45% ± 8%. Top tier: ≥53% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| RBC Capital | 100% | 4/4 | 76.7% | top tier |
| Barclays | 70% | 7/10 | 11.4% | top tier |
| Oppenheimer | 67% | 6/9 | 10.9% | top tier |
| Jefferies | 67% | 2/3 | 8.5% | top tier |
| Citigroup | 63% | 5/8 | 43% | top tier |
| JP Morgan | 60% | 3/5 | 38.9% | top tier |
| Benchmark | 55% | 6/11 | 36.4% | top tier |
| UBS | 55% | 6/11 | 26.6% | top tier |
| Roth Capital | 50% | 1/2 | -8.4% | above average |
| Wells Fargo | 50% | 4/8 | 0.9% | above average |
TD Cowen has a 45% accuracy rate on 2,051 scored calls with an average return of 3.6%, placing it below the average of firms covering MRVL. Top performers on MRVL include RBC Capital (100% on 4 calls, avg return 76.7%), Barclays (70% on 10 calls, avg return 11.4%), and Oppenheimer (67% on 9 calls, avg return 10.9%). The worst performer among those with sufficient data is Rosenblatt (42% on 12 calls, avg return 26.2%).
Earnings Estimates
Next earnings: Nov 26, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $7.36 | $6.22 to $8.21 | $19.8B | ↑24 ↓0 |
| 0y | $4.22 | $3.92 to $4.61 | $12.1B | ↑6 ↓0 |
| 0q | $1.10 | $1.08 to $1.14 | $3.2B | ↑2 ↓0 |
| +1q | $1.36 | $1.25 to $1.48 | $3.7B | ↑6 ↓0 |
Cross-Platform Signals
Insider trades show heavy selling: CEO Matthew Murphy sold $1.68M (10b5-1 plan) on Sep 15 and $1.77M (10b5-1) on Oct 15; COO Chris Koopmans sold $2.62M (10b5-1) on Oct 1; President Sandeep Bharathi sold $866K (10b5-1) on Oct 16; and SVP Justin Scarpulla sold $301K (non-plan) on Oct 8. Total insider sales exceed $7.2M, all open-market sells. Congressional trades show small sells by Reps. Salazar and Khanna, and a small buy by Khanna in August. Institutional activity is mixed: two funds added (MATHER +34%, Robeco +31.3%) while two trimmed (Assenagon -50.7%, Prime Capital -28.1%). The insider selling aligns with the bearish analyst signal, adding joint informativeness.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
49 reports on MRVL
10 of 14 bullish or bearish reports moved the stock their way by T+1. Best: +145.40% at T+60 after the Mar 5, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 12, 20264d ago 8-K Neutral 2/10 Entry $164.45 to $156.76 Now $145.36 −11.61% ▼ −4.68% −4.31% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $133.55 to $141.20 Now $145.36 +8.84% ▲ +5.73% +5.42% vs SPY
- Nov 3, 202613d ago ANALYST-DOWNGRADE Bearish 6/10 Viewing Entry $171.97 to $159.80 Now $145.36 +15.47% ▲ +7.08% +8.73% vs SPY
- Nov 3, 202613d ago ANALYST-DOWNGRADE Bearish 5/10 Entry $171.97 to $159.80 Now $145.36 +15.47% ▲ +7.08% +8.73% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $171.97 to $159.80 Now $145.36 −15.47% ▼ −7.08% −8.73% vs SPY
- Nov 2, 202614d ago 425 Mixed 7/10 Entry $171.41 to $171.97 Now $145.36 −15.20% ▲ +0.33% +0.03% vs SPY
- Nov 2, 202614d ago 425 Mixed 7/10 Entry $171.41 to $171.97 Now $145.36 −15.20% ▲ +0.33% +0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers